Clinical Trial Update: Neurocognitive and Metabolic Effects of Mild Hypothyroidism [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating neurocognitive and metabolic effects of mild hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Snippet

Sponsor: Oregon Health and Science University | Conditions: Hypothyroidism | Phase 4 | Status: COMPLETED | Results posted: 2018-08-22